Phillips-Medisize announces a significant company expansion in Suzhou, China

HUDSON, WI – May 17, 2018 – phillipsmedisize – Phillips-Medisize, a Molex company, has announced a significant company expansion in Suzhou, China. The company has added approximately 140,000 sq. ft. (13,000 sq. m.) of medical manufacturing space near the company’s existing site, expanding not only the company’s manufacturing abilities and capacity in China, but also the design and development services as well.

Phillips-Medisize will manufacture both drug delivery and medical devices at the facility, which is slated to begin production next month. The state-of-the-art facility will also offer clean room molding and clean room assembly. The new Suzhou site will be fully integrated with other Phillips-Medisize sites around the globe, providing common worldwide quality standards and design controls, along with local service and manufacturing support. Additionally, Phillips-Medisize’s continuum of services, coupled with the vertical integration of Molex’s electronics, provides comprehensive end-to-end Connected Health solutions.“The expansion confirms the ‘Asia for Asia’ strategy we announced four years ago, as we continue to see significant growth and demand of customers in this region,” remarked Matt Jennings, President Phillips-Medisize. “This expansion builds on Phillips-Medisize’s already-strong reputation for manufacturing excellence and expertise, ensuring that customers in Asia are able to take advantage of the same capabilities and services that are available in the United States and Europe.”This will be the company’s seventh expansion in the past six years to support long-term growth of its medical contract development and manufacturing business. These investments demonstrate ongoing support for biopharmaceutical and medtech customers by providing design, development and manufacturing solutions for both mechanical and connected devices across multiple geographies.